I am a fellowship-trained orthopaedic surgeon and I perform primary and revision total hip replacements, total knee replacements and partial knee replacements using a robotic-assisted system. I treat patients with osteoarthritis, rheumatoid arthritis or avascular necrosis.
I am the Director of Adult Reconstruction Research with research interests in total hip, total knee, and partial knee replacement outcomes and prevention and management of total joint complications such as periprosthetic infections. Further interests include value based care and access to care in total joint arthroplasty to decrease health care disparities.
My clinical research has focused on value based care and health care delivery of total joint arthroplasty to patient with lower economic status. The number of total joint arthroplasties is predicted to increase significantly in the next decade; however, access to these procedure remains limited to patients with lower socioeconomic status. Alternative payment model implemented by the Centers for Medicare & Medicaid Services may further limit joint arthroplasty to healthier patients potentially excluding certain populations. Understanding barriers to care access and improving these patients outcomes has been a focus of my work, view all of my publications.
Unicompartmental knee arthroplasties are approximately 8-10% of all knee arthroplasties performed in the US. However, up to 80% are possible candidates for unicompartmental knee arthroplasties with advantages such as shorter operative time, less blood and improved functional outcomes and satisfaction. My research has found that previous inclusion criteria have becomes obsolete with modern robotic-assisted surgery which allows for more precise and accurate implant placement and provides dynamic ligament balancing that may improve implant longevity.
My research has also focused the prevention and management of complications after total hip and total knee replacement. My recent research has focused on the influence of osteoarthritis and the role of cartilage oligomeric matrix protein on metastatic disease in patients with prostate cancer and whether a history of prostate cancer has an effect on the outcomes following total hip or total knee arthroplasty.